Our top pick for
Dynatrace, Inc is a software-application business based in the US. Dynatrace shares (DT) are listed on the NYSE and all prices are listed in US Dollars. Dynatrace employs 2,243 staff and has a trailing 12-month revenue of around USD$657.6 million.
|52-week range||USD$17.1 - USD$56.77|
|50-day moving average||USD$48.6312|
|200-day moving average||USD$42.2754|
|Wall St. target price||USD$59.15|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-1417.93|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Dynatrace stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Dynatrace's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Dynatrace's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 94x. In other words, Dynatrace shares trade at around 94x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Dynatrace's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$124 million.
The EBITDA is a measure of a Dynatrace's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$657.6 million|
|Operating margin TTM||12.03%|
|Gross profit TTM||USD$433.3 million|
|Return on assets TTM||2.38%|
|Return on equity TTM||9.75%|
|Market capitalisation||USD$14.7 billion|
TTM: trailing 12 months
There are currently 5.5 million Dynatrace shares held short by investors – that's known as Dynatrace's "short interest". This figure is 43.3% down from 9.8 million last month.
There are a few different ways that this level of interest in shorting Dynatrace shares can be evaluated.
Dynatrace's "short interest ratio" (SIR) is the quantity of Dynatrace shares currently shorted divided by the average quantity of Dynatrace shares traded daily (recently around 2.8 million). Dynatrace's SIR currently stands at 2. In other words for every 100,000 Dynatrace shares traded daily on the market, roughly 2000 shares are currently held short.
However Dynatrace's short interest can also be evaluated against the total number of Dynatrace shares, or, against the total number of tradable Dynatrace shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Dynatrace's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Dynatrace shares in existence, roughly 20 shares are currently held short) or 0.0341% of the tradable shares (for every 100,000 tradable Dynatrace shares, roughly 34 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Dynatrace.
Find out more about how you can short Dynatrace stock.
We're not expecting Dynatrace to pay a dividend over the next 12 months.
Dynatrace, Inc. provides a software intelligence platform for the enterprise cloud applications. It operates Dynatrace, a platform for running and optimizing multi-cloud environments. Its products include AppMon that works in various application environments, such as mobile apps, web apps, web browsers, web servers, Java, .NET, Node.js, PHP, databases, middleware, and mainframe; and Classic Real User Monitoring, which tracks user's experience from an edge devices comprising smart phones, tablets, PCs, or kiosk through cloud services, as well as customer's web tiers. The company also provides Synthetic Classic, which offers customer experience, as well as is used to monitor application and application program interface availability and performance; and Network Application Monitoring that provides enterprise applications, network services, user experience, and application delivery across wide-area networks. Its platform allows its customers to modernize and automate IT operations, develop and release software, and enhance user experiences. The company also offers implementation, consulting, and training services. Dynatrace, Inc. markets its products through a combination of direct sales team and a network of partners, including resellers, system integrators, and managed service providers. It serves customers in various industries comprising banking, insurance, retail, manufacturing, travel, and software. The company operates in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. Dynatrace, Inc. is headquartered in Waltham, Massachusetts.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
Everything we know about the SEMrush Holdings Inc IPO, plus information on how to buy in.
Everything we know about the ChargePoint IPO, plus information on how to buy in.
Everything we know about the Kaltura Inc IPO, plus information on how to buy in.
Everything we know about the Rocket Lab IPO, plus information on how to buy in.
Everything we know about the Soho House IPO, plus information on how to buy in.
Everything we know about the VIZIO IPO, plus information on how to buy in.
Everything we know about the IDW Media Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Karooooo Ltd IPO, plus information on how to buy in.
Everything we know about the Connect Biopharma Holdings Limited IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.